Literature DB >> 15925367

Voltammetric determination of montelukast sodium in dosage forms and human plasma.

I Alsarra1, M Al-Omar, E A Gadkariem, F Belal.   

Abstract

The voltammetric behaviour of montelukast (MKST) was studied using cyclic voltammetry, direct current (DCt), differential pulse polarography (DPP) and alternating current (ACt) polarography. MKST exhibited well-defined cathodic waves over the range pH range 1-5. No anodic waves were produced over the same pH range. At pH 1, the analytical pH; the diffusion current constant (Id) was 2.2+/-0.01 microA l mmol-1. The current concentration plot was rectilinear over the range 2-20 microg ml-1 with correlation coefficient (n=10) of 0.9943. The lower limit of detection (S/N=2) was 0.2 microg ml-1 (3.41x10(-7) M). The wave has been characterised as being diffusion-controlled, although adsorption phenomenon played a limited role in the electrode reaction. The proposed method was successfully applied to the determination of MKST in commercial tablets, and results were in agreement with those given with a reference HPLC method. The method was further extended to the in vitro determination of the drug in spiked human plasma. The mean % recovery (n=5) was 101.38+/-3.85. The number of electrons transferred in the reduction process could be accomplished and a proposal of the electrode reaction was proposed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925367     DOI: 10.1016/j.farmac.2005.04.004

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  8 in total

1.  Development and validation of RP-HPLC method with ultraviolet detection for estimation of montelukast in rabbit plasma: Application to preclinical pharmacokinetics.

Authors:  Om Prakash Ranjan; Usha Y Nayak; Meka Sreenivasa Reddy; Swapnil J Dengale; Prashant B Musmade; Nayanabhirama Udupa
Journal:  J Young Pharm       Date:  2013-11-26

2.  Determination of Montelukast in Plasma Using β - Cyclodextrins Coated on CoFe2O4 Magnetic Nanoparticles in Luminol-H2O2 Chemiluminescence System Optimized by Doehlert Design.

Authors:  Abdolraouf Samadi-Maybodi; Alireza Bakhtiar; Mohammad Hossein Fatemi
Journal:  J Fluoresc       Date:  2016-03-15       Impact factor: 2.217

3.  Method development and validation of montelukast in human plasma by HPLC coupled with ESI-MS/MS: application to a bioequivalence study.

Authors:  Balasekhara Reddy Challa; Bahlul Z Awen; Babu Rao Chandu; Mukkanti Khagga; Chandrasekhar Bannoth Kotthapalli
Journal:  Sci Pharm       Date:  2010-06-04

4.  Development and validation of LC/MS/MS method for the simultaneous determination of montelukast, gliclazide, and nifedipine and its application to a pharmacokinetic study.

Authors:  Essam Ezzeldin; Nisreen F Abo-Talib; Marwa H Tammam; Abdelaaty A Shahat
Journal:  Chem Cent J       Date:  2014-03-11       Impact factor: 4.215

5.  HPTLC-Densitometric Determination of Cetirizine and Montelukast Analysis in Combined Tablet Dosage Forms.

Authors:  Saeed Haghighi; Mahmoud Reza Shapouri; Mitra Amoli-Diva; Kamyar Pourghazi; Hossein Afruzi
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

6.  UV-Vis Spectrophotometry and Multivariate Calibration Method for Simultaneous Determination of Theophylline, Montelukast and Loratadine in Tablet Preparations and Spiked Human Plasma.

Authors:  Seyed Karim Hassaninejad-Darzi; Abdolraouf Samadi-Maybodi; Seyed Mohsen Nikou
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

7.  Quick simultaneous analysis of bambuterol and montelukast based on synchronous spectrofluorimetric technique.

Authors:  Rania El Gamal; Samah Abo El Abass; Heba M Elmansi
Journal:  R Soc Open Sci       Date:  2020-12-09       Impact factor: 2.963

8.  Stability-indicating HPLC Method for Simultaneous Determination of Montelukast and Fexofenadine Hydrochloride.

Authors:  Mona Pankhaniya; Parula Patel; J S Shah
Journal:  Indian J Pharm Sci       Date:  2013-05       Impact factor: 0.975

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.